A 24-year-old SMA patient in Kerala High Court revealed that Risdiplam, a crucial SMA drug, could be locally produced for Rs 3,000 annually compared to the current Rs 72 lakh. Highlighting the need for local manufacturing, the petition challenges the sufficiency of the Indian Health Ministry's financial aid and crowdfunding efforts.
